# Verisk Analytics, Inc.: financial statements, quarterly

VRSK · Nasdaq · CIK 1442145 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrsk.md) · [Financials](/companies/vrsk/financials.md) · [Filings](/companies/vrsk/filings.md) · [Insiders](/companies/vrsk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vrsk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [675](/filings/0001437749-24-023985.md) | [678](/filings/0001437749-24-032536.md) | [677 d](/filings/0001437749-26-004452.md) | [704](/filings/0001437749-25-014907.md) | [717](/filings/0001437749-25-023862.md) | [725](/filings/0001437749-25-032073.md) | [736 d](/filings/0001437749-26-004452.md) | [753](/filings/0001437749-26-013729.md) | [773](/filings/0001437749-25-023862.md) | [768](/filings/0001437749-25-032073.md) | [779 d](/filings/0001437749-26-004452.md) | [783](/filings/0001437749-26-013729.md) |
| Cost of revenue | $m | [217](/filings/0001437749-24-023985.md) | [217](/filings/0001437749-24-032536.md) | [226 d](/filings/0001437749-26-004452.md) | [228](/filings/0001437749-25-014907.md) | [219](/filings/0001437749-25-023862.md) | [223](/filings/0001437749-25-032073.md) | [231 d](/filings/0001437749-26-004452.md) | [231](/filings/0001437749-26-013729.md) | [230](/filings/0001437749-25-023862.md) | [230](/filings/0001437749-25-032073.md) | [236 d](/filings/0001437749-26-004452.md) | [237](/filings/0001437749-26-013729.md) |
| Selling, general and administrative | $m | [86.8](/filings/0001437749-24-023985.md) | [112](/filings/0001437749-24-032536.md) | [114 d](/filings/0001437749-26-004452.md) | [92.9](/filings/0001437749-25-014907.md) | [102](/filings/0001437749-25-023862.md) | [114](/filings/0001437749-25-032073.md) | [100 d](/filings/0001437749-26-004452.md) | [109](/filings/0001437749-26-013729.md) | [107](/filings/0001437749-25-023862.md) | [111](/filings/0001437749-25-032073.md) | [132 d](/filings/0001437749-26-004452.md) | [110](/filings/0001437749-26-013729.md) |
| Operating income | $m | [306](/filings/0001437749-24-023985.md) | [281](/filings/0001437749-24-032536.md) | [251 d](/filings/0001437749-26-004452.md) | [307](/filings/0001437749-25-014907.md) | [319](/filings/0001437749-25-023862.md) | [312](/filings/0001437749-25-032073.md) | [316 d](/filings/0001437749-26-004452.md) | [330](/filings/0001437749-26-013729.md) | [354](/filings/0001437749-25-023862.md) | [346](/filings/0001437749-25-032073.md) | [314 d](/filings/0001437749-26-004452.md) | [352](/filings/0001437749-26-013729.md) |
| Interest expense | $m | [31.6](/filings/0001437749-24-023985.md) | [29.4](/filings/0001437749-24-032536.md) | [28.1 d](/filings/0001437749-24-004939.md) | [28.9](/filings/0001437749-24-014064.md) | [29.1](/filings/0001437749-24-023985.md) | [32.1](/filings/0001437749-24-032536.md) | [34.5 d](/filings/0001437749-26-004452.md) | [36.3](/filings/0001437749-26-013729.md) | [35.5](/filings/0001437749-25-023862.md) | [42.2](/filings/0001437749-25-032073.md) | [56.9 d](/filings/0001437749-26-004452.md) | [43.2](/filings/0001437749-26-013729.md) |
| Income tax | $m | [63.9](/filings/0001437749-24-023985.md) | [62.3](/filings/0001437749-24-032536.md) | [60.4 d](/filings/0001437749-26-004452.md) | [55.8](/filings/0001437749-25-014907.md) | [85.2](/filings/0001437749-25-023862.md) | [65.3](/filings/0001437749-25-032073.md) | [71.6 d](/filings/0001437749-26-004452.md) | [64.1](/filings/0001437749-26-013729.md) | [74.6](/filings/0001437749-25-023862.md) | [76.6](/filings/0001437749-25-032073.md) | [47.7 d](/filings/0001437749-26-004452.md) | [74.3](/filings/0001437749-26-013729.md) |
| Net income | $m | [197](/filings/0001437749-24-023985.md) | [187](/filings/0001437749-24-032536.md) | [174 d](/filings/0001437749-26-004452.md) | [220](/filings/0001437749-25-014907.md) | [308](/filings/0001437749-25-023862.md) | [220](/filings/0001437749-25-032073.md) | [210 d](/filings/0001437749-26-004452.md) | [232](/filings/0001437749-26-013729.md) | [253](/filings/0001437749-25-023862.md) | [226](/filings/0001437749-25-032073.md) | [197 d](/filings/0001437749-26-004452.md) | [234](/filings/0001437749-26-013729.md) |
| Diluted EPS | $ per share | [1.35](/filings/0001437749-24-023985.md) | [1.29](/filings/0001437749-24-032536.md) | not reported | [1.52](/filings/0001437749-25-014907.md) | [2.15](/filings/0001437749-25-023862.md) | [1.54](/filings/0001437749-25-032073.md) | not reported | [1.65](/filings/0001437749-26-013729.md) | [1.81](/filings/0001437749-25-023862.md) | [1.61](/filings/0001437749-25-032073.md) | not reported | [1.73](/filings/0001437749-26-013729.md) |
| Basic EPS | $ per share | [1.36](/filings/0001437749-24-023985.md) | [1.29](/filings/0001437749-24-032536.md) | not reported | [1.53](/filings/0001437749-25-014907.md) | [2.16](/filings/0001437749-25-023862.md) | [1.55](/filings/0001437749-25-032073.md) | not reported | [1.66](/filings/0001437749-26-013729.md) | [1.81](/filings/0001437749-25-023862.md) | [1.62](/filings/0001437749-25-032073.md) | not reported | [1.73](/filings/0001437749-26-013729.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [309](/filings/0001437749-23-021529.md) | [417](/filings/0001437749-23-029653.md) | [303](/filings/0001437749-25-005160.md) | [352](/filings/0001437749-24-014064.md) | [632](/filings/0001437749-24-023985.md) | [458](/filings/0001437749-24-032536.md) | [291](/filings/0001437749-26-004452.md) | [1,112](/filings/0001437749-25-014907.md) | [629](/filings/0001437749-25-023862.md) | [2,108](/filings/0001437749-25-032073.md) | [2,178](/filings/0001437749-26-013729.md) | [525](/filings/0001437749-26-013729.md) |
| Current assets | $m | [855](/filings/0001437749-23-021529.md) | [928](/filings/0001437749-23-029653.md) | [810](/filings/0001437749-25-005160.md) | [1,017](/filings/0001437749-24-014064.md) | [1,307](/filings/0001437749-24-023985.md) | [1,093](/filings/0001437749-24-032536.md) | [912](/filings/0001437749-26-004452.md) | [1,772](/filings/0001437749-25-014907.md) | [1,377](/filings/0001437749-25-023862.md) | [2,695](/filings/0001437749-25-032073.md) | [2,765](/filings/0001437749-26-013729.md) | [1,202](/filings/0001437749-26-013729.md) |
| Total assets | $m | [4,316](/filings/0001437749-23-021529.md) | [4,364](/filings/0001437749-23-029653.md) | [4,366](/filings/0001437749-25-005160.md) | [4,499](/filings/0001437749-24-014064.md) | [4,768](/filings/0001437749-24-023985.md) | [4,563](/filings/0001437749-24-032536.md) | [4,265](/filings/0001437749-26-004452.md) | [5,122](/filings/0001437749-25-014907.md) | [4,795](/filings/0001437749-25-023862.md) | [6,242](/filings/0001437749-25-032073.md) | [6,196](/filings/0001437749-26-013729.md) | [4,598](/filings/0001437749-26-013729.md) |
| Current liabilities | $m | [801](/filings/0001437749-23-021529.md) | [784](/filings/0001437749-23-029653.md) | [771](/filings/0001437749-25-005160.md) | [930](/filings/0001437749-24-014064.md) | [1,371](/filings/0001437749-24-023985.md) | [1,335](/filings/0001437749-24-032536.md) | [1,239](/filings/0001437749-26-004452.md) | [1,398](/filings/0001437749-25-014907.md) | [899](/filings/0001437749-25-023862.md) | [2,259](/filings/0001437749-25-032073.md) | [2,300](/filings/0001437749-26-013729.md) | [1,181](/filings/0001437749-26-013729.md) |
| Total liabilities | $m | [4,010](/filings/0001437749-23-021529.md) | [3,969](/filings/0001437749-23-029653.md) | [4,044](/filings/0001437749-25-005160.md) | [4,211](/filings/0001437749-24-014064.md) | [4,333](/filings/0001437749-24-023985.md) | [4,259](/filings/0001437749-24-032536.md) | [4,160](/filings/0001437749-26-004452.md) | [4,998](/filings/0001437749-25-014907.md) | [4,482](/filings/0001437749-25-023862.md) | [5,864](/filings/0001437749-25-032073.md) | [5,886](/filings/0001437749-26-013729.md) | [5,765](/filings/0001437749-26-013729.md) |
| Long-term debt | $m | not reported | not reported | [2,884](/filings/0001437749-24-004939.md) | not reported | not reported | not reported | [3,091](/filings/0001437749-25-005160.md) | not reported | not reported | not reported | [4,774](/filings/0001437749-26-004452.md) | not reported |
| Current portion of debt | $m | [3.4](/filings/0001437749-23-021529.md) | [12.4](/filings/0001437749-23-029653.md) | [14.5](/filings/0001437749-25-005160.md) | [16.4](/filings/0001437749-24-014064.md) | [517](/filings/0001437749-24-023985.md) | [516](/filings/0001437749-24-032536.md) | [514](/filings/0001437749-26-004452.md) | [518](/filings/0001437749-25-014907.md) | [17.0](/filings/0001437749-25-023862.md) | [1,489](/filings/0001437749-25-032073.md) | [1,509](/filings/0001437749-26-013729.md) | [258](/filings/0001437749-26-013729.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [294](/filings/0001437749-23-021529.md) | [385](/filings/0001437749-23-029653.md) | [310](/filings/0001437749-25-005160.md) | [282](/filings/0001437749-24-014064.md) | [430](/filings/0001437749-24-023985.md) | [300](/filings/0001437749-24-032536.md) | [100](/filings/0001437749-26-004452.md) | [123](/filings/0001437749-25-014907.md) | [312](/filings/0001437749-25-023862.md) | [377](/filings/0001437749-25-032073.md) | [309](/filings/0001437749-26-013729.md) | [(1,168)](/filings/0001437749-26-013729.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [193](/filings/0001437749-24-023985.md) | [250](/filings/0001437749-24-032536.md) | [252 d](/filings/0001437749-26-004452.md) | [372](/filings/0001437749-25-014907.md) | [212](/filings/0001437749-25-023862.md) | [296](/filings/0001437749-25-032073.md) | [255 d](/filings/0001437749-26-004452.md) | [445](/filings/0001437749-26-013729.md) | [245](/filings/0001437749-25-023862.md) | [404](/filings/0001437749-25-032073.md) | [343 d](/filings/0001437749-26-004452.md) | [390](/filings/0001437749-26-013729.md) |
| Capital expenditure | $m | [58.2](/filings/0001437749-24-023985.md) | [54.3](/filings/0001437749-24-032536.md) | [56.3 d](/filings/0001437749-26-004452.md) | [55.2](/filings/0001437749-25-014907.md) | [57.8](/filings/0001437749-25-023862.md) | [55.5](/filings/0001437749-25-032073.md) | [55.4 d](/filings/0001437749-26-004452.md) | [53.7](/filings/0001437749-26-013729.md) | [55.8](/filings/0001437749-25-023862.md) | [67.4](/filings/0001437749-25-032073.md) | [67.2 d](/filings/0001437749-26-004452.md) | [64.0](/filings/0001437749-26-013729.md) |
| Dividends paid | $m | [49.5](/filings/0001437749-24-023985.md) | [49.2](/filings/0001437749-24-032536.md) | [48.9 d](/filings/0001437749-26-004452.md) | [55.8](/filings/0001437749-25-014907.md) | [55.5](/filings/0001437749-25-023862.md) | [55.3](/filings/0001437749-25-032073.md) | [54.7 d](/filings/0001437749-26-004452.md) | [63.0](/filings/0001437749-26-013729.md) | [63.0](/filings/0001437749-25-023862.md) | [62.6](/filings/0001437749-25-032073.md) | [62.5 d](/filings/0001437749-26-004452.md) | [65.5](/filings/0001437749-26-013729.md) |
| Share repurchases | $m | [0.0](/filings/0001437749-24-023985.md) | [49.8](/filings/0001437749-24-032536.md) | [713 d](/filings/0001437749-26-004452.md) | [170](/filings/0001437749-25-014907.md) | [128](/filings/0001437749-25-023862.md) | [340](/filings/0001437749-25-032073.md) | [315 d](/filings/0001437749-26-004452.md) | [170](/filings/0001437749-26-013729.md) | [100](/filings/0001437749-25-023862.md) | [100](/filings/0001437749-25-032073.md) | [224 d](/filings/0001437749-26-004452.md) | [1,402](/filings/0001437749-26-013729.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [159](/filings/0001437749-23-021529.md) | [158](/filings/0001437749-23-029653.md) | [153](/filings/0001437749-24-014064.md) | [146](/filings/0001437749-24-023985.md) | [146](/filings/0001437749-24-032536.md) | [144](/filings/0001437749-25-014907.md) | [143](/filings/0001437749-25-023862.md) | [143](/filings/0001437749-25-032073.md) | [141](/filings/0001437749-26-013729.md) | [140](/filings/0001437749-25-023862.md) | [140](/filings/0001437749-25-032073.md) | [135](/filings/0001437749-26-013729.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 131,021,840 at 2026-04-24, from the cover of the [10-Q filed 2026-04-29](/filings/0001437749-26-013729.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.